Gregory R Friberg

EVP, Chief R&D Officer, BioMarin Pharmaceutical

Bought, 12 months

$0.0M

Sold, 12 months

$0.6M

Companies

Latest trade

May 7, 2026

Companies

BioMarin PharmaceuticalEVP, Chief R&D Officer −$0.6M

Trades

BMRN Sold 3,281 shares at $53.85 $0.2M May 7

BMRN Sold 6,326 shares at $60.38 $0.4M Feb 26

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.